Jennifer D'Angelo

Jennifer D'Angelo has a diverse background in the life sciences industry with a focus on business development and commercial partnerships. Their most recent position was as a Director, Commercial Partnerships at Seer, starting in March 2023. Prior to that, they worked as the Director, Strategic Accounts at SomaLogic from November 2021 to March 2023.

Before moving to Seer and SomaLogic, Jennifer had several roles in business development within the life sciences sector. Jennifer was a Business Development Manager at Olink Proteomics from October 2019 to November 2021, where they focused on accelerating proteomics and enabling new discoveries. Prior to that, Jennifer served as the Director of Business Development at Biocrates Life Sciences AG from June 2018 to October 2019, where they provided solutions for biological questions through targeted metabolomics and profiling services.

Earlier in their career, Jennifer worked as a Business Development Specialist at Eurofins Pharma Discovery Services from June 2017 to June 2018 and as a Business Development Manager at Crown Bioscience, Inc. from December 2016 to May 2017. Jennifer also has experience outside of the life sciences industry, having worked as a Volunteer Captain at the Houston Super Bowl Host Committee from November 2016 to March 2017.

Jennifer began their career in the life sciences field at NSF Health Sciences, where they worked as a Business Development Manager from March 2016 to October 2016. Jennifer was responsible for generating leads and opportunities in the Southeast territory. Jennifer also worked at Metabolon as a Senior Science Development Director from March 2011 to March 2016, where they contributed to the advancement of precision medicine through metabolomics-based diagnostic tests.

Before joining Metabolon, Jennifer worked at Harlan Laboratories, Inc. as an Account Executive from October 2009 to June 2011. In this role, they achieved significant sales success and managed a large territory of accounts in Texas.

Overall, Jennifer D'Angelo brings extensive experience in business development and commercial partnerships within the life sciences industry, with a strong focus on accelerating scientific discoveries and advancing precision medicine.

Jennifer D'Angelo obtained their Bachelor of Science degree in Biology from the University of Houston in the years 2000-2002. Jennifer then pursued their Master of Business Administration (MBA) from the University of St. Thomas (TX) from 2006-2008.